866-997-4948(US-Canada Toll Free)

Global Intranasal Drug Delivery Market Insights, Forecast to 2025

Published By :

QYResearch

Published Date : Aug 2018

Category :

Pharmaceutical

No. of Pages : 100 Pages

This report studies the global market size of Intranasal Drug Delivery in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Intranasal Drug Delivery in these regions.
This research report categorizes the global Intranasal Drug Delivery market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Intranasal drug delivery system is a medical device used for the administration of drugs for the treatment of local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. Intranasal Drug Delivery Devices are medical devices used for drug delivery through noses.
The classification of Intranasal Drug Delivery Devices includes Multidose and Uni/bidose, and the proportion of Multidose in 2017 is about 85%, and the proportion is in decreasing trend from 2013 to 2017.

North America, especially The United States, will still play an important role which cannot be ignored, with market size of 340 million USD in 2017 and will be 770 million USD in 2025. Any changes from United States might affect the development trend of Intranasal Drug Delivery Devices. North America region is the largest consumer of Intranasal Drug Delivery Devices, with a market share nearly 43% in 2017.

Europe also plays important roles in global market, with market size of 270 million USD in 2017, enjoying sales market share nearly 34% in 2017.The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
In 2017, the global Intranasal Drug Delivery market size was 780 million US$ and is forecast to 1730 million US in 2025, growing at a CAGR of 10.5% from 2018. The objectives of this study are to define, segment, and project the size of the Intranasal Drug Delivery market based on company, product type, application and key regions.

The various contributors involved in the value chain of Intranasal Drug Delivery include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Intranasal Drug Delivery include
BD
AptarGroup
3M
Teleflex
HT Presspart
Bespak
Pfizer
Novartis
Becton Dickinson
Johnson & Johnson
Merck
GlaxoSmithKline
Nemera
OptiNose
AstraZeneca

Market Size Split by Type
Multidose
Uni/bidose
Market Size Split by Application
Personal Use
Hospital Use

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Intranasal Drug Delivery market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Intranasal Drug Delivery market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Intranasal Drug Delivery manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Intranasal Drug Delivery with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Intranasal Drug Delivery submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Intranasal Drug Delivery are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Intranasal Drug Delivery market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 Intranasal Drug Delivery Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Intranasal Drug Delivery Market Size Growth Rate by Type
1.4.2 Multidose
1.4.3 Uni/bidose
1.5 Market by Application
1.5.1 Global Intranasal Drug Delivery Market Size Growth Rate by Application
1.5.2 Personal Use
1.5.3 Hospital Use
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Intranasal Drug Delivery Market Size
2.1.1 Global Intranasal Drug Delivery Revenue 2016-2025
2.1.2 Global Intranasal Drug Delivery Sales 2016-2025
2.2 Intranasal Drug Delivery Growth Rate by Regions
2.2.1 Global Intranasal Drug Delivery Sales by Regions
2.2.2 Global Intranasal Drug Delivery Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Intranasal Drug Delivery Sales by Manufacturers
3.1.1 Intranasal Drug Delivery Sales by Manufacturers
3.1.2 Intranasal Drug Delivery Sales Market Share by Manufacturers
3.1.3 Global Intranasal Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.2 Intranasal Drug Delivery Revenue by Manufacturers
3.2.1 Intranasal Drug Delivery Revenue by Manufacturers (2016-2018)
3.2.2 Intranasal Drug Delivery Revenue Share by Manufacturers (2016-2018)
3.3 Intranasal Drug Delivery Price by Manufacturers
3.4 Intranasal Drug Delivery Manufacturing Base Distribution, Product Types
3.4.1 Intranasal Drug Delivery Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Intranasal Drug Delivery Product Category
3.4.3 Date of International Manufacturers Enter into Intranasal Drug Delivery Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Intranasal Drug Delivery Sales by Type
4.2 Global Intranasal Drug Delivery Revenue by Type
4.3 Intranasal Drug Delivery Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Intranasal Drug Delivery Breakdown Data by Application

6 North America
6.1 North America Intranasal Drug Delivery by Countries
6.1.1 North America Intranasal Drug Delivery Sales by Countries
6.1.2 North America Intranasal Drug Delivery Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Intranasal Drug Delivery by Type
6.3 North America Intranasal Drug Delivery by Application
6.4 North America Intranasal Drug Delivery by Company

7 Europe
7.1 Europe Intranasal Drug Delivery by Countries
7.1.1 Europe Intranasal Drug Delivery Sales by Countries
7.1.2 Europe Intranasal Drug Delivery Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Intranasal Drug Delivery by Type
7.3 Europe Intranasal Drug Delivery by Application
7.4 Europe Intranasal Drug Delivery by Company

8 Asia Pacific
8.1 Asia Pacific Intranasal Drug Delivery by Countries
8.1.1 Asia Pacific Intranasal Drug Delivery Sales by Countries
8.1.2 Asia Pacific Intranasal Drug Delivery Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Intranasal Drug Delivery by Type
8.3 Asia Pacific Intranasal Drug Delivery by Application
8.4 Asia Pacific Intranasal Drug Delivery by Company

9 Central & South America
9.1 Central & South America Intranasal Drug Delivery by Countries
9.1.1 Central & South America Intranasal Drug Delivery Sales by Countries
9.1.2 Central & South America Intranasal Drug Delivery Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Intranasal Drug Delivery by Type
9.3 Central & South America Intranasal Drug Delivery by Application
9.4 Central & South America Intranasal Drug Delivery by Company

10 Middle East and Africa
10.1 Middle East and Africa Intranasal Drug Delivery by Countries
10.1.1 Middle East and Africa Intranasal Drug Delivery Sales by Countries
10.1.2 Middle East and Africa Intranasal Drug Delivery Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Intranasal Drug Delivery by Type
10.3 Middle East and Africa Intranasal Drug Delivery by Application
10.4 Middle East and Africa Intranasal Drug Delivery by Company

11 Company Profiles
11.1 BD
11.1.1 BD Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Intranasal Drug Delivery
11.1.4 Intranasal Drug Delivery Product Description
11.1.5 Recent Development
11.2 AptarGroup
11.2.1 AptarGroup Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Intranasal Drug Delivery
11.2.4 Intranasal Drug Delivery Product Description
11.2.5 Recent Development
11.3 3M
11.3.1 3M Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Intranasal Drug Delivery
11.3.4 Intranasal Drug Delivery Product Description
11.3.5 Recent Development
11.4 Teleflex
11.4.1 Teleflex Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Intranasal Drug Delivery
11.4.4 Intranasal Drug Delivery Product Description
11.4.5 Recent Development
11.5 HT Presspart
11.5.1 HT Presspart Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Intranasal Drug Delivery
11.5.4 Intranasal Drug Delivery Product Description
11.5.5 Recent Development
11.6 Bespak
11.6.1 Bespak Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Intranasal Drug Delivery
11.6.4 Intranasal Drug Delivery Product Description
11.6.5 Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Intranasal Drug Delivery
11.7.4 Intranasal Drug Delivery Product Description
11.7.5 Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Intranasal Drug Delivery
11.8.4 Intranasal Drug Delivery Product Description
11.8.5 Recent Development
11.9 Becton Dickinson
11.9.1 Becton Dickinson Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Intranasal Drug Delivery
11.9.4 Intranasal Drug Delivery Product Description
11.9.5 Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Intranasal Drug Delivery
11.10.4 Intranasal Drug Delivery Product Description
11.10.5 Recent Development
11.11 Merck
11.12 GlaxoSmithKline
11.13 Nemera
11.14 OptiNose
11.15 AstraZeneca

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Intranasal Drug Delivery Raw Material
13.1.2 Intranasal Drug Delivery Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Intranasal Drug Delivery
Figure Global Intranasal Drug Delivery Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Intranasal Drug Delivery Production Market Share by Types (Product Category) in 2017
Figure Multidose Product Picture
Table Major Manufacturers of Multidose
Figure Uni/bidose Product Picture
Table Major Manufacturers of Uni/bidose
Table Global Intranasal Drug Delivery Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Personal Use
Figure Hospital Use
Figure Intranasal Drug Delivery Report Years Considered
Figure Global Intranasal Drug Delivery Market Size 2016-2025 (Million US$)
Figure Global Intranasal Drug Delivery Sales 2016-2025 (K Units)
Table Global Intranasal Drug Delivery Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Intranasal Drug Delivery Sales by Regions 2016-2025 (K Units)
Table Global Intranasal Drug Delivery Sales Market Share by Regions 2016-2025
Figure Global Intranasal Drug Delivery Sales Market Share by Regions 2016-2025
Figure 2017 Global Intranasal Drug Delivery Sales Market Share by Regions
Table Global Intranasal Drug Delivery Revenue by Regions 2016-2025 (Million US$)
Table Global Intranasal Drug Delivery Revenue Market Share by Regions 2016-2025
Figure Global Intranasal Drug Delivery Revenue Market Share by Regions 2016-2025
Figure 2017 Global Intranasal Drug Delivery Revenue Market Share by Regions
Table Global Intranasal Drug Delivery Sales by Manufacturers (2016-2018) (K Units)
Table Global Intranasal Drug Delivery Sales Share by Manufacturers (2016-2018)
Figure Global Intranasal Drug Delivery Sales Share by Manufacturers in 2017
Table Intranasal Drug Delivery Revenue by Manufacturers (2016-2018) (Million US$)
Table Intranasal Drug Delivery Revenue Share by Manufacturers (2016-2018)
Figure Intranasal Drug Delivery Value Share by Manufacturers in 2017
Table Global Intranasal Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Intranasal Drug Delivery Price (2016-2018) (USD/Unit)
Table Intranasal Drug Delivery Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Intranasal Drug Delivery Product Category
Table Date of International Manufacturers Enter into Intranasal Drug Delivery Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Intranasal Drug Delivery Sales by Type (2016-2025) (K Units)
Table Global Intranasal Drug Delivery Sales Share by Type (2016-2025)
Figure Global Intranasal Drug Delivery Sales Market Share by Type (2016-2025)
Figure Global Intranasal Drug Delivery Sales Market Share by Type in 2017
Table Global Intranasal Drug Delivery Revenue by Type (2016-2025) (Million US$)
Table Global Intranasal Drug Delivery Revenue Share by Type (2016-2025)
Figure Global Intranasal Drug Delivery Revenue Market Share by Type (2016-2025)
Figure Global Intranasal Drug Delivery Revenue Market Share by Type in 2017
Table Intranasal Drug Delivery Price by Type 2013-2018 (USD/Unit)
Table Global Intranasal Drug Delivery Sales by Application (2016-2025) (K Units)
Table Global Intranasal Drug Delivery Sales Share by Application (2016-2025)
Figure Global Sales Intranasal Drug Delivery Market Share by Application (2016-2025)
Figure Global Sales Intranasal Drug Delivery Market Share by Application (2016-2025)
Figure North America Intranasal Drug Delivery Sales Growth Rate 2016-2025 (K Units)
Figure North America Intranasal Drug Delivery Revenue Growth Rate 2016-2025 (Million US$)
Table North America Intranasal Drug Delivery Sales by Countries (2016-2025) (K Units)
Table North America Intranasal Drug Delivery Sales Market Share by Countries (2016-2025)
Figure 2017 North America Intranasal Drug Delivery Sales Market Share by Countries
Table North America Intranasal Drug Delivery Revenue by Countries (2016-2025) (Million US$)
Table North America Intranasal Drug Delivery Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Intranasal Drug Delivery Revenue Market Share by Countries
Figure United States Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure United States Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure Canada Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Table North America Intranasal Drug Delivery Sales by Type (2016-2025) (K Units)
Table North America Intranasal Drug Delivery Sales Market Share by Type (2016-2025)
Figure 2017 North America Intranasal Drug Delivery Market Share by Type
Table North America Intranasal Drug Delivery Sales by Application (2016-2025) (K Units)
Table North America Intranasal Drug Delivery Sales Market Share by Application (2016-2025)
Figure 2017 North America Intranasal Drug Delivery Market Share by Application
Table North America Intranasal Drug Delivery Sales by Company (2016-2018) (K Units)
Table North America Intranasal Drug Delivery Sales Market Share by Company (2016-2018)
Figure North America Intranasal Drug Delivery Sales Market Share by Company in 2017
Figure Europe Intranasal Drug Delivery Sales Growth Rate 2016-2025 (K Units)
Figure Europe Intranasal Drug Delivery Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Intranasal Drug Delivery Sales by Countries (2016-2025) (K Units)
Table Europe Intranasal Drug Delivery Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Intranasal Drug Delivery Sales Market Share by Countries
Table Europe Intranasal Drug Delivery Revenue by Countries (2016-2025) (Million US$)
Table Europe Intranasal Drug Delivery Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Intranasal Drug Delivery Revenue Market Share by Countries
Figure Germany Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure Germany Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (K Units)
Figure France Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure France Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (K Units)
Figure UK Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure UK Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure Italy Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure Russia Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Intranasal Drug Delivery Sales by Type (2016-2025) (K Units)
Table Europe Intranasal Drug Delivery Sales Market Share by Type (2016-2025)
Figure 2017 Europe Intranasal Drug Delivery Market Share by Type
Table Europe Intranasal Drug Delivery Sales by Application (2016-2025) (K Units)
Table Europe Intranasal Drug Delivery Sales Market Share by Application (2016-2025)
Figure 2017 Europe Intranasal Drug Delivery Market Share by Application
Table Europe Intranasal Drug Delivery Sales by Company (2016-2018) (K Units)
Table Europe Intranasal Drug Delivery Sales Market Share by Company (2016-2018)
Figure Europe Intranasal Drug Delivery Sales Market Share by Company in 2017
Figure Asia Pacific Intranasal Drug Delivery Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Intranasal Drug Delivery Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Intranasal Drug Delivery Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Intranasal Drug Delivery Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Intranasal Drug Delivery Sales Market Share by Countries
Table Asia Pacific Intranasal Drug Delivery Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Intranasal Drug Delivery Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Intranasal Drug Delivery Revenue Market Share by Countries
Figure China Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure China Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure Japan Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure Korea Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Figure India Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure India Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure Australia Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Intranasal Drug Delivery Sales by Type (2016-2025) (K Units)
Table Asia Pacific Intranasal Drug Delivery Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Intranasal Drug Delivery Market Share by Type
Table Asia Pacific Intranasal Drug Delivery Sales by Application (2016-2025) (K Units)
Table Asia Pacific Intranasal Drug Delivery Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Intranasal Drug Delivery Market Share by Application
Table Asia Pacific Intranasal Drug Delivery Sales by Company (2016-2018) (K Units)
Table Asia Pacific Intranasal Drug Delivery Sales Market Share by Company (2016-2018)
Figure Asia Pacific Intranasal Drug Delivery Sales Market Share by Company in 2017
Figure Central & South America Intranasal Drug Delivery Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Intranasal Drug Delivery Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Intranasal Drug Delivery Sales by Countries (2016-2025) (K Units)
Table Central & South America Intranasal Drug Delivery Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Intranasal Drug Delivery Sales Market Share by Countries
Table Central & South America Intranasal Drug Delivery Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Intranasal Drug Delivery Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Intranasal Drug Delivery Revenue Market Share by Countries
Figure Brazil Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Intranasal Drug Delivery Sales by Type (2016-2025) (K Units)
Table Central & South America Intranasal Drug Delivery Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Intranasal Drug Delivery Market Share by Type
Table Central & South America Intranasal Drug Delivery Sales by Application (2016-2025) (K Units)
Table Central & South America Intranasal Drug Delivery Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Intranasal Drug Delivery Market Share by Application
Table Central & South America Intranasal Drug Delivery Sales by Company (2016-2018) (K Units)
Table Central & South America Intranasal Drug Delivery Sales Market Share by Company (2016-2018)
Figure Central & South America Intranasal Drug Delivery Sales Market Share by Company in 2017
Figure Middle East and Africa Intranasal Drug Delivery Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Intranasal Drug Delivery Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Intranasal Drug Delivery Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Intranasal Drug Delivery Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Intranasal Drug Delivery Sales Market Share by Countries
Table Middle East and Africa Intranasal Drug Delivery Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Intranasal Drug Delivery Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Intranasal Drug Delivery Revenue Market Share by Countries
Figure GCC Countries Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Intranasal Drug Delivery Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Intranasal Drug Delivery Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Intranasal Drug Delivery Market Share by Type
Table Middle East and Africa Intranasal Drug Delivery Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Intranasal Drug Delivery Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Intranasal Drug Delivery Market Share by Application
Table Middle East and Africa Intranasal Drug Delivery Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Intranasal Drug Delivery Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Intranasal Drug Delivery Sales Market Share by Company in 2017
Table BD Company Details
Table BD Intranasal Drug Delivery Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table BD Recent Development
Table AptarGroup Company Details
Table AptarGroup Intranasal Drug Delivery Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table AptarGroup Recent Development
Table 3M Company Details
Table 3M Intranasal Drug Delivery Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table 3M Recent Development
Table Teleflex Company Details
Table Teleflex Intranasal Drug Delivery Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Teleflex Recent Development
Table HT Presspart Company Details
Table HT Presspart Intranasal Drug Delivery Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table HT Presspart Recent Development
Table Bespak Company Details
Table Bespak Intranasal Drug Delivery Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Bespak Recent Development
Table Pfizer Company Details
Table Pfizer Intranasal Drug Delivery Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Pfizer Recent Development
Table Novartis Company Details
Table Novartis Intranasal Drug Delivery Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Novartis Recent Development
Table Becton Dickinson Company Details
Table Becton Dickinson Intranasal Drug Delivery Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Becton Dickinson Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Intranasal Drug Delivery Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Johnson & Johnson Recent Development
Table Merck Company Details
Table GlaxoSmithKline Company Details
Table Nemera Company Details
Table OptiNose Company Details
Table AstraZeneca Company Details
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Intranasal Drug Delivery Value Chain
Table Typical Suppliers of Key Intranasal Drug Delivery Raw Material
Table Intranasal Drug Delivery Customers List
Table Intranasal Drug Delivery Sales Channels
Table Intranasal Drug Delivery Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *